Family · Pharmaceutical analytical standards
Xylometazoline
A nasal decongestant derived from imidazole that narrows the vessels of the nasal lining by stimulating alpha-adrenergic receptors; patented in 1956 and in use since 1959, it is applied as a spray or drops. This family brings together pharmacopoeial impurities, labelled standards and nitrosamines.
Did you know?Its molecule was designed to mimic the shape of adrenaline, and it has been included in the World Health Organization's Model List of Essential Medicines.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
